Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001477932-17-004894
Filing Date
2017-10-05
Accepted
2017-10-05 11:02:28
Documents
33
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A aepp_10qa.htm 10-Q/A 204825
2 CERTIFICATION aepp_ex311.htm EX-31.1 8100
3 CERTIFICATION aepp_ex321.htm EX-32.1 3187
  Complete submission text file 0001477932-17-004894.txt   1167976

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT aepp-20170630.xml EX-101.INS 108839
5 XBRL TAXONOMY EXTENSION SCHEMA aepp-20170630.xsd EX-101.SCH 20554
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aepp-20170630_cal.xml EX-101.CAL 21287
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aepp-20170630_def.xml EX-101.DEF 56057
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aepp-20170630_lab.xml EX-101.LAB 103516
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aepp-20170630_pre.xml EX-101.PRE 96036
Mailing Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014
Business Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014 281-402-3167
Oncolix, Inc. (Filer) CIK: 0001584137 (see all company filings)

EIN.: 463046340 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-55545 | Film No.: 171123591
SIC: 2834 Pharmaceutical Preparations